Joel R Jung

CIK 1373488 · Interim Chief Financial Office · last filed 2024-06-13

Joel R Jung is an Interim Chief Financial Office who has filed 6 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing, for RNLX, was dated Jun 13, 2024. Current disclosed insider exposure totals $22 across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$22

Companies

3

Total Filings

6

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Renalytix plc (RNLX) Delisted Interim Chief Financial Office $0.21 $0 1 2024-06-13
UTRS CFO 220,730 $0.00 $22 $0 2 2022-08-09
Celera CORP (CRA) Delisted VP, CFO & Treasurer 38,553 $0 3 2008-08-25

Recent Filings

6 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-06-13 Renalytix plc (RNLX) Delisted Grant (A) $0 EDGAR
2022-08-09 UTRS Grant (A) +60,198 $0 EDGAR
2021-12-17 UTRS Grant (A) +24,500 $0 EDGAR
2008-08-25 Celera CORP (CRA) Delisted Mixed −2,612 -$23.9K EDGAR
2007-08-20 Celera CORP (CRA) Delisted Mixed +1,745 -$12.8K EDGAR
2007-01-31 Celera CORP (CRA) Delisted Grant (A) $0 EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.